News
In an effort to foster progress in cancer research, the National Institute of Standards and Technology (NIST) is releasing detailed and comprehensive data about the entire genetic content of a ...
According to experts at the IAS 2025 meeting in Kigali, Rwanda, AI revolutionizes HIV vaccine development by enhancing design ...
Canine and human cancers bear many similarities, and studies on dogs are helping advance care for our furry friends and for ...
The privately funded basket trial makes good on its aim to enroll underrepresented groups amid a DEI-hostile federal funding ...
Astria Therapeutics' Navenibart shows promise in phase 3 trials for hereditary angioedema. Click here to find out why ATXS ...
ARPA-H, part of HHS, has earmarked up to $142 million for 10 research projects building the tools, data, and infrastructure needed to tackle treatment resistance.
2d
Health and Me on MSNCancer Clinical Trials Face Low Participation - Why Are More People Not Encouraged To Try?Cancer, a disease long though incurable, has been not only treated, but also through research and trials. Healthcare professionals have also found ways that help people be cancer-free. However, recent ...
4d
Migraine Again on MSNIs Participating in a Migraine Clinical Trial Worth It? Benefits, Drawbacks, and What to ExpectConsidering a migraine clinical trial? Learn about the types, benefits, risks, and eligibility, along with what questions you should ask to see if participating is right for you.
A recent study found that only 15% of cancer survivors discussed trials with their healthcare providers, with ...
Gain insights to de-risk and accelerate your trials. Explore with us the value of integrating precision medicine into your clinical trials — from patient selection to operational efficiency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results